EPMA summit 2014 under the auspices of the presidency of Italy in the EU: professional statements

Over the next 10–20 years, a pessimistic prognosis considers pandemic scenario for type 2 diabetes mellitus, neurodegenerative disorders and some types of cancer followed by the economic disaster of healthcare systems in a global scale. Well-recognised deficits of currently provided medical services result from the delayed ‘disease care’. Herewith EPMA releases the long-term strategies for the effective promotion of predictive, preventive and personalised medicine (PPPM) considered as the medicine of the future. Under the EPMA-umbrella, an international forum of currently 45 countries is actively contributing to the development and implementation of the innovative PPPM concepts. EPMA is open for collaboration with other leading European and global professional networks relevant for the effective promotion of PPPM in sciences and practical implementation.

[1]  S. Mandel.  Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future , 2013 .

[2]  Paolo Roberti di Sarsina,et al.  Traditional, complementary and alternative medical systems and their contribution to personalisation, prediction and prevention in medicine—person-centred medicine , 2012, EPMA Journal.

[3]  H. Krumholz.  Lipoprotein-Associated Phospholipase A , 2001 .

[4]  Mauro Alivia,et al.  Towards salutogenesis in the development of personalised and preventive healthcare , 2011, EPMA Journal.

[5]  Olga Golubnitschaja,et al.  Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper , 2014, EPMA Journal.

[6]  E. Wanker,et al.  Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? , 2013, EPMA Journal.

[7]  Ana C. Fonseca,et al.  Drug delivery systems: Advanced technologies potentially applicable in personalized treatments , 2010, EPMA Journal.

[8]  Meral Özgüç,et al.  A new book “Rare Diseases: Integrative PPPM Approach as the Medicine of the Future” , 2014, EPMA Journal.

[9]  M. Mozaffari.  New strategies to advance pre/diabetes care: integrative approach by PPPM , 2014, EPMA Journal.

[10]  Dominic M. Desiderio,et al.  The use of variations in proteomes to predict, prevent, and personalize treatment for clinically nonfunctional pituitary adenomas , 2010, EPMA Journal.

[11]  P. Gahan.  Circulating Nucleic Acids in Early Diagnosis, Prognosis and Treatment Monitoring , 2015 .

[12]  C. Cafiero,et al.  Predictive, preventive, personalised and participatory periodontology: ‘the 5Ps age’ has already started , 2013, EPMA Journal.

[13]  S. Karabulut.  Advances in Predictive, Preventive and Personalised Medicine , 2012 .

[14]  G. Trovato.  Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine , 2012, EPMA Journal.

[15]  O. Golubnitschaja,et al.  Dental health: EPMA recommendations for innovative strategies , 2014, EPMA Journal.

[16]  O. Golubnitschaja,et al.  General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine , 2012, EPMA Journal.

[17]  H. Iso.  Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases , 2011, EPMA Journal.

[18]  H. Deigner.  Challenges in biobanking in personalized medicine – a biobank society’s view , 2014, EPMA Journal.

[19]  S. Titze,et al.  Physical activity recommendations for public health: development and policy context , 2011, EPMA Journal.

[20]  H. Schild,et al.  Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? , 2013, EPMA Journal.

[21]  S. Hagan,et al.  Targeted therapies in colorectal cancer—an integrative view by PPPM , 2013, EPMA Journal.

[22]  Yuxiang Yan,et al.  Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health , 2014, EPMA Journal.

[23]  Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon? , 2012, EPMA Journal.

[24]  Sverre Sandberg,et al.  Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care , 2013, EPMA Journal.

[25]  Paolo Roberti di Sarsina,et al.  Why we need integrative medicine , 2011, EPMA Journal.

[26]  Rostyslav V Bubnov.  Evidence-based pain management: is the concept of integrative medicine applicable? , 2012, EPMA Journal.

[27]  Pre-graduate and post-graduate education in personalized medicine in the Czech Republic: statistics, analysis and recommendations , 2014, EPMA Journal.

[28]  C. Graf.  Preventing and treating obesity in pediatrics through physical activity , 2011, EPMA Journal.

[29]  R. Andrews,et al.  Unpredictable, unpreventable and impersonal medicine: global disaster response in the 21st century , 2015, EPMA Journal.

[30]  Paul Marschall,et al.  Individualized medicine – ethical, economical and historical perspectives , 2014, EPMA Journal.

[31]  O. Golubnitschaja.  Time for new guidelines in advanced healthcare: the mission of The EPMA Journal to promote an integrative view in predictive, preventive and personalized medicine , 2012, EPMA Journal.

[32]  H. Lemke,et al.  An Information Technology Framework for Predictive, Preventive and Personalised Medicine , 2015 .

[33]  Rostyslav V Bubnov,et al.  Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology , 2013, EPMA Journal.

[34]  X. Zhan,et al.  Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer , 2013, EPMA Journal.

[35]  Prediction and personalised treatment of atrial fibrillation—stroke prevention: consolidated position paper of CVD professionals , 2014, EPMA Journal.

[36]  Tatsuya Ohno,et al.  Particle radiotherapy with carbon ion beams , 2013, EPMA Journal.

[37]  V. Costigliola.  Healthcare overview: new perspectives , 2014, EPMA Journal.

[38]  E. Drucker,et al.  Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine , 2013, EPMA Journal.

[39]  Rostyslav V Bubnov,et al.  EPMA position paper in cancer: current overview and future perspectives , 2015, EPMA Journal.

[40]  A. Döring,et al.  Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy , 2012, EPMA Journal.

[41]  Michael E. Cobble,et al.  Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk , 2011, EPMA Journal.

[42]  J. Polívka,et al.  Personalized approach to primary and secondary prevention of ischemic stroke , 2014, EPMA Journal.

[43]  S. Mandel,et al.  Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy , 2010, EPMA Journal.

[44]  H. Lemke,et al.  Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within ‘Horizon 2020’ , 2014, EPMA Journal.

[45]  H. Lemke,et al.  Advances in Predictive, Preventive and Personalised Medicine , 2015 .

[46]  M. Hofmann-Apitius,et al.  From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine , 2013, EPMA Journal.

[47]  K. Krapfenbauer,et al.  The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicine , 2010, EPMA Journal.

[48]  K. Krapfenbauer,et al.  Economic concerns about global healthcare in lung, head and neck cancer: meeting the economic challenge of predictive, preventive and personalized medicine , 2010, EPMA Journal.

[49]  M. Morelli,et al.  Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care , 2011, EPMA Journal.

[50]  Niva Shapira,et al.  Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine , 2013, EPMA Journal.

[51]  N. Moiseeva,et al.  A novel approach for detection of primary tooth caries based on the light influence foundation , 2014, EPMA Journal.

[52]  Godfrey Grech,et al.  Preventive and Predictive Genetics: Towards Personalised Medicine , 2015 .